Drug comparisons
Pioglitazone vs Sotagliflozin
Pioglitazone (TZD) reduces insulin resistance with black box warning for heart failure, Sotagliflozin (SGLT2/1) lowers glucose and heart load w/o black box warning.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes experiencing insulin resistance or heart-related complications may compare these two antidiabetic medications.
Bottom line
Both Pioglitazone and Sotagliflozin are valuable options for managing type 2 diabetes, but the optimal choice varies based on individual patient characteristics and medical history.
All medication comparisons